null

Biotinylated Anti-CA9 (Girentuximab biosimilar) mAb (HDBS0240)

SKU:
HDBS0240
Antibody Type:
Biotinylated Biosimilar
Modifications:
Biotinylated
Applications:
IHC
SPR
FC
ELISA
Drug Development
Pharmacokinetics
Disease Area:
Cancer
Size:
100 μg
Target:
CA9
Isotype:
IgG1
Host Species:
Chimeric
Reactivity:
Human
€429

Description

system_update_altDatasheetsystem_update_altMSDS